跳到主要內容

Sutter Martin P 的 Form 4 申報

Abiomed IncABMD,2022/2/17 申報

申報編號
0001179110-22-001397
申報時間
2022/2/17
交易日
2022/2/15
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $60.7 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Sutter Martin PCIK 0001017832董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/2/15Common Stock, $0.01 par valueS賣出處分−11$296.18F2−$3,257.98138,379直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−32$298.50F3−$9,552138,347直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−157$301.00F4−$47,257138,190直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−159$301.56F5−$47,948.04138,031直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−312$302.70F6−$94,442.4137,719直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−460$303.65F7−$139,679137,259直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−536$304.52F8−$163,222.72136,723直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−185$305.71F9−$56,556.35136,538直接
2022/2/15Common Stock, $0.01 par valueS賣出處分−148$306.68F10−$45,388.64136,390直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This price represents the sale price of the transactions on the reported date at $296.18. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F3

This price represents the sale price of the transactions on the reported date at $298.50. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F4

This price represents the sale price of the transactions on the reported date at $301.0046. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F5

This price represents the sale price of the transactions on the reported date at $301.5608. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F6

This price represents the sale price of the transactions on the reported date at $302.6986. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F7

This price represents the sale price of the transactions on the reported date at $303.6477. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F8

This price represents the sale price of the transactions on the reported date at $304.5160. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F9

This price represents the sale price of the transactions on the reported date at $305.7072. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

F10

This price represents the sale price of the transactions on the reported date at $306.6811. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)